Sunday, January 14, 2024
HomeNanotechnologyAdministration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates...

Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice | Journal of Nanobiotechnology


  • Kepp O, Loos F, Liu P, Kroemer G. Extracellular nucleosides and nucleotides as immunomodulators. Immunol Rev. 2017;280:83–92.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Rissiek B, Haag F, Boyer O, Koch-Nolte F, Adriouch S. P2X7 on mouse T cells: one channel, many capabilities. Entrance Immunol. 2015;6:204.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mishra A, Behura A, Kumar A, Naik L, Swain A, Das M, Sarangi SS, Dokania P, Dirisala VR, Bhutia SK, et al. P2X7 receptor in multifaceted mobile signalling and its relevance as a possible therapeutic goal in numerous illnesses. Eur J Pharmacol. 2021;906: 174235.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Schwarz N, Fliegert R, Adriouch S, Seman M, Guse AH, Haag F, Koch-Nolte F. Activation of the P2X7 ion channel by soluble and covalently sure ligands. Purinergic Sign. 2009;5:139–49.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5’-triphosphate and adenosine as endogenous signaling molecules in immunity and irritation. Pharmacol Ther. 2006;112:358–404.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hubert S, Rissiek B, Klages Ok, Huehn J, Sparwasser T, Haag F, Koch-Nolte F, Boyer O, Seman M, Adriouch S. Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment by way of the ART2-P2X7 pathway. J Exp Med. 2010;207:2561–8.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gu B, Bendall LJ, Wiley JS. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the identical receptor however totally different metalloproteases. Blood. 1998;92:946–51.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Scheuplein F, Schwarz N, Adriouch S, Krebs C, Bannas P, Rissiek B, Seman M, Haag F, Koch-Nolte F. NAD+ and ATP launched from injured cells induce P2X7-dependent shedding of CD62L and externalization of phosphatidylserine by murine T cells. J Immunol. 2009;182:2898–908.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Moon H, Na HY, Chong KH, Kim TJ. P2X7 receptor-dependent ATP-induced shedding of CD27 in mouse lymphocytes. Immunol Lett. 2006;102:98–105.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Grassi F. The P2X7 receptor as regulator of T cell growth and performance. Entrance Immunol. 2020;11:1179.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Grassi F, Marino R. The P2X7 receptor in mucosal adaptive immunity. Purinergic Sign. 2023. https://doi.org/10.1007/s11302-023-09939-w.

    Article 
    PubMed 

    Google Scholar
     

  • Pelegrin P. P2X7 receptor and the NLRP3 inflammasome: Companions in crime. Biochem Pharmacol. 2021;187: 114385.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Mitra S, Sarkar A. Microparticulate P2X7 and GSDM-D mediated regulation of purposeful IL-1beta launch. Purinergic Sign. 2019;15:119–23.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S. The P2X7 receptor in an infection and irritation. Immunity. 2017;47:15–31.

    Article 
    PubMed 

    Google Scholar
     

  • Liu JP, Liu SC, Hu SQ, Lu JF, Wu CL, Hu DX, Zhang WJ. ATP ion channel P2X purinergic receptors in irritation response. Biomed Pharmacother. 2023;158: 114205.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Cheng N, Zhang L, Liu L. Understanding the position of purinergic P2X7 receptors within the gastrointestinal system: a scientific evaluate. Entrance Pharmacol. 2021;12: 786579.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Liu Y, Liu X. Analysis progress of P2X7 receptor in inflammatory bowel illness. Scand J Gastroenterol. 2019;54:521–7.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Heiss Ok, Janner N, Mahnss B, Schumacher V, Koch-Nolte F, Haag F, Mittrucker HW. Excessive sensitivity of intestinal CD8+ T cells to nucleotides signifies P2X7 as a regulator for intestinal T cell responses. J Immunol. 2008;181:3861–9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Trautmann A. Extracellular ATP within the immune system: greater than only a “hazard sign.” Sci Sign. 2009;2:pe6.

    Article 
    PubMed 

    Google Scholar
     

  • Cesaro A, Brest P, Hofman V, Hebuterne X, Wildman S, Ferrua B, Marchetti S, Doglio A, Vouret-Craviari V, Galland F, et al. Amplification loop of the inflammatory course of is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration. Am J Physiol Gastrointest Liver Physiol. 2010;299:G32-42.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Jiang ZF, Wu W, Hu HB, Li ZY, Zhong M, Zhang L. P2X7 receptor because the regulator of T-cell operate in intestinal barrier disruption. World J Gastroenterol. 2022;28:5265–79.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Neves AR, Castelo-Branco MT, Figliuolo VR, Bernardazzi C, Buongusto F, Yoshimoto A, Nanini HF, Coutinho CM, Carneiro AJ, Coutinho-Silva R, de Souza HS. Overexpression of ATP-activated P2X7 receptors within the intestinal mucosa is implicated within the pathogenesis of Crohn’s illness. Inflamm Bowel Dis. 2014;20:444–57.

    Article 
    PubMed 

    Google Scholar
     

  • Saber S, Youssef ME, Sharaf H, Amin NA, El-Shedody R, Aboutouk FH, El-Galeel YA, El-Hefnawy A, Shabaka D, Khalifa A, et al. BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by concentrating on P2X7R/NLRP3 and MyD88/NF-kappaB signaling in DSS-induced colitis in rats. Life Sci. 2021;270: 119123.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hofman P, Cherfils-Vicini J, Bazin M, Ilie M, Juhel T, Hébuterne X, Gilson E, Schmid-Alliana A, Boyer O, Adriouch S, Vouret-Craviari V. Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens irritation however will increase tumor incidence in a mouse mannequin of colitis-associated most cancers. Most cancers Res. 2015;75:835–45.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bernardazzi C, Castelo-Branco MTL, Pego B, Ribeiro BE, Rosas SLB, Santana PT, Machado JC, Leal C, Thompson F, Coutinho-Silva R, de Souza HSP. The P2X7 receptor promotes colorectal irritation and tumorigenesis by modulating intestine microbiota and the inflammasome. Int J Mol Sci. 2022;23:4616.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Illes P, Muller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, et al. Replace of P2X receptor properties and their pharmacology: IUPHAR evaluate 30. Br J Pharmacol. 2021;178:489–514.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Muyldermans S. Nanobodies: pure single-domain antibodies. Annu Rev Biochem. 2013;82:775–97.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Danquah W, Meyer-Schwesinger C, Rissiek B, Pinto C, Serracant-Prat A, Amadi M, Iacenda D, Knop JH, Hammel A, Bergmann P, et al. Nanobodies that block gating of the P2X7 ion channel ameliorate irritation. Sci Transl Med. 2016;8:366ra162.

    Article 
    PubMed 

    Google Scholar
     

  • Koch-Nolte F, Eichhoff A, Pinto-Espinoza C, Schwarz N, Schafer T, Menzel S, Haag F, Demeules M, Gonde H, Adriouch S. Novel biologics concentrating on the P2X7 ion channel. Curr Opin Pharmacol. 2019;47:110–8.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Danquah W, Koch-Nolte F, Stortelers C, Toon L. P2X7 receptor antagonists and agonists, vol. WO2013178783A1. Munich: European Patent Workplace; 2013.


    Google Scholar
     

  • Demeules M, Scarpitta A, Abad C, Gonde H, Hardet R, Pinto-Espinoza C, Eichhoff AM, Schafer W, Haag F, Koch-Nolte F, Adriouch S. Analysis of P2X7 receptor operate in tumor contexts utilizing rAAV vector and nanobodies (AAVnano). Entrance Oncol. 2020;10:1699.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Seman M, Adriouch S, Scheuplein F, Krebs C, Freese D, Glowacki G, Deterre P, Haag F, Koch-Nolte F. NAD-induced T cell loss of life: ADP-ribosylation of cell floor proteins by ART2 prompts the cytolytic P2X7 purinoceptor. Immunity. 2003;19:571–82.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Adriouch S, Hubert S, Pechberty S, Koch-Nolte F, Haag F, Seman M. NAD+ launched throughout irritation participates in T cell homeostasis by inducing ART2-mediated loss of life of naive T cells in vivo. J Immunol. 2007;179:186–94.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Pinto-Espinoza Carolina, Guillou C, Rissiek B, Wilmes M, Javidi E, Schwarz N, Junge M, Haag F, Liaukouskaya N, Wanner N, Nicke A, Stortelers C, Tan Y-T, Adriouch S, Magnus T, Koch-Nolte F. Efficient concentrating on of microglial P2X7 following intracerebroventricular supply of nanobodies and nanobody-encoding AAVs. Entrance Pharmacol. 2022;13. https://doi.org/10.3389/fphar.2022.1029236.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Eichele DD, Kharbanda KK. Dextran sodium sulfate colitis murine mannequin: an indispensable device for advancing our understanding of inflammatory bowel illnesses pathogenesis. World J Gastroenterol. 2017;23:6016–29.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Colella P, Ronzitti G, Mingozzi F. Rising points in AAV-mediated in vivo gene remedy. Mol Ther Strategies Clin Dev. 2018;8:87–104.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Pupo A, Fernandez A, Low SH, Francois A, Suarez-Amaran L, Samulski RJ. AAV vectors: the Rubik’s dice of human gene remedy. Mol Ther. 2022;30:3515–41.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Srivastava A. Rationale and techniques for the event of secure and efficient optimized AAV vectors for human gene remedy. Mol Ther Nucleic Acids. 2023;32:949–59.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene remedy supply. Nat Rev Drug Discov. 2019;18:358–78.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Fu Q, Polanco A, Lee YS, Yoon S. Essential challenges and advances in recombinant adeno-associated virus (rAAV) biomanufacturing. Biotechnol Bioeng. 2023. https://doi.org/10.1002/bit.28412.

    Article 
    PubMed 

    Google Scholar
     

  • Li C, Samulski RJ. Engineering adeno-associated virus vectors for gene remedy. Nat Rev Genet. 2020;21:255–72.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Shen W, Liu S, Ou L. rAAV immunogenicity, toxicity, and sturdiness in 255 scientific trials: A meta-analysis. Entrance Immunol. 2022;13:1001263.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Grossen P, Skaripa Koukelli I, van Haasteren J, Machado AHE, Duerr C. The ice age: a evaluate on formulation of adeno-associated virus therapeutics. Eur J Pharm Biopharm. 2023. https://doi.org/10.1016/j.ejpb.2023.07.002.

    Article 
    PubMed 

    Google Scholar
     

  • Balazs AB, Bloom JD, Hong CM, Rao DS, Baltimore D. Broad safety towards influenza an infection by vectored immunoprophylaxis in mice. Nat Biotechnol. 2013;31:647–52.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Brady JM, Baltimore D, Balazs AB. Antibody gene switch with adeno-associated viral vectors as a way for HIV prevention. Immunol Rev. 2017;275:324–33.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Metzger MW, Walser SM, Aprile-Garcia F, Dedic N, Chen A, Holsboer F, Arzt E, Wurst W, Deussing JM. Genetically dissecting P2rx7 expression inside the central nervous system utilizing conditional humanized mice. Purinergic Sign. 2017;13:153–70.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Vultaggio-Poma V, Falzoni S, Salvi G, Giuliani AL, Di Virgilio F. Signalling by extracellular nucleotides in well being and illness. Biochim Biophys Acta Mol Cell Res. 2022;1869: 119237.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wan P, Liu X, Xiong Y, Ren Y, Chen J, Lu N, Guo Y, Bai A. Extracellular ATP mediates inflammatory responses in colitis by way of P2 x 7 receptor signaling. Sci Rep. 2016;6:19108.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Marques CC, Castelo-Branco MT, Pacheco RG, Buongusto F, Rosario A, Schanaider A, Coutinho-Silva R, de Souza HS. Prophylactic systemic P2X7 receptor blockade prevents experimental colitis. Biochim Biophys Acta. 2014;1842:65–78.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Evangelinellis MM, Souza RF, Mendes CE, Castelucci P. Results of a P2X7 receptor antagonist on myenteric neurons within the distal colon of an experimental rat mannequin of ulcerative colitis. Histochem Cell Biol. 2022;157:65–81.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Jo S, Bean BP. Inhibition of neuronal voltage-gated sodium channels by good blue G. Mol Pharmacol. 2011;80:247–57.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Homerin G, Jawhara S, Dezitter X, Baudelet D, Dufrenoy P, Rigo B, Millet R, Furman C, Rage G, Lipka E, et al. Pyroglutamide-based P2X7 receptor antagonists concentrating on inflammatory bowel illness. J Med Chem. 2020;63:2074–94.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wetzel A, Scholtka B, Gerecke C, Kleuser B. Epigenetic histone modulation contributes to enhancements in inflammatory bowel illness by way of EBI3. Cell Mol Life Sci. 2020;77:5017–30.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen Z, Wang S, Li L, Huang Z, Ma Ok. Anti-inflammatory impact of IL-37-producing T-cell inhabitants in DSS-induced continual inflammatory bowel illness in mice. Int J Mol Sci. 2018;19:3884.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Berry D, Kuzyk O, Rauch I, Heider S, Schwab C, Hainzl E, Decker T, Muller M, Strobl B, Schleper C, et al. Intestinal microbiota signatures related to irritation historical past in mice experiencing recurring colitis. Entrance Microbiol. 2015;6:1408.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jiang Q, Li W, Zhu X, Yu L, Lu Z, Liu Y, Ma B, Cheng L. Estrogen receptor beta alleviates inflammatory lesions in a rat mannequin of inflammatory bowel illness by way of down-regulating P2X7R expression in macrophages. Int J Biochem Cell Biol. 2021;139: 106068.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Gurevich EV, Gurevich VV. Therapeutic potential of small molecules and engineered proteins. Handb Exp Pharmacol. 2014;219:1–12.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nemetz N, Abad C, Lawson G, Nobuta H, Chhith S, Duong L, Tse G, Braun J, Waschek JA. Induction of colitis and fast growth of colorectal tumors in mice poor within the neuropeptide PACAP. Int J Most cancers. 2008;122(8):1803–9. https://doi.org/10.1002/ijc.23308.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gonde H, Demeules M, Hardet R, Scarpitta A, Junge M, Pinto-Espinoza C, Varin R, Koch-Nolte F, Boyer O, Adriouch S. A methodological method utilizing rAAV vectors encoding nanobody-based biologics to guage ARTC2.2 and P2X7 in vivo. Entrance Immunol. 2021;12:704408.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ghetie V, Popov S, Borvak J, Radu C, Matesoi D, Medesan C, Ober RJ, Ward ES. Growing the serum persistence of an IgG fragment by random mutagenesis. Nat Biotechnol. 1997;15:637–40.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Scheuplein F, Rissiek B, Driver JP, Chen YG, Koch-Nolte F, Serreze DV. A recombinant heavy chain antibody method blocks ART2 mediated deletion of an iNKT cell inhabitants that upon activation inhibits autoimmune diabetes. J Autoimmun. 2010;34:145–54.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Curtis MJ, Alexander S, Cirino G, Docherty JR, George CH, Giembycz MA, Hoyer D, Insel PA, Izzo AA, Ji Y, MacEwan DJ, Sobey CG, Stanford SC, Teixeira MM, Wonnacott S, Ahluwalia A. Experimental design and evaluation and their reporting II: up to date and simplified steering for authors and peer reviewers. Br J Pharmacol. 2018;175(7):987–93. https://doi.org/10.1111/bph.14153.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     



  • Supply hyperlink

    RELATED ARTICLES

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    - Advertisment -
    Google search engine

    Most Popular

    Recent Comments